National pre-settlement funding provider continues strategic focus on late-stage, mid-stage, and emerging pharmaceutical and medical device litigation JERSEY CITY, N.J., March 5, 2026 /PRNewswire/ -- ...
Lawyers nationwide are gearing up for bellwether ovarian cancer trials against Johnson & Johnson this year, but a plaintiff ...
Arbutus and Genevant's complaint claimed that Moderna's mRNA-based Spikevax shot used lipid nanoparticle (LNP) delivery ...
Law firms behind cases aligned with Health Secretary Robert F. Kennedy Jr.’s Make America Healthy Again movement are eyeing a new litigation front.
As the secondary market for pre‑IPO shares continues to mature, transactions involving the private stock of late‑stage ...
In today’s complex litigation landscape, many individuals and businesses are turning to alternative methods to resolve disputes as a way to avoid the time, expense, and unpredictability of traditional ...
Clause Law Group today released a public guide outlining what families should look for when selecting the best wrongful ...
The rise of AI and a shifting regulatory environment are challenging traditional approaches to securities litigation. We talked to Eric Poer to find out more.
"The 2025 PLUS D&O Symposium brought together leading voices in the professional liability space to discuss the evolving risks corporate leaders are facing. I was privileged to moderate the panel on ...
Saying costs to North Carolina households is an estimated $800 to $1,300 this year because of government tariffs, Attorney ...
The surge in vaccine litigation is not simply a post-pandemic, temporary issue. It is a deeper erosion of the legal principles that have long supported public health authority.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results